Ocugen, Inc. SEC filings OCGN

Ocugen, Inc. has 892 filings in SEC EDGAR's recent list, going back to Aug 7, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Ocugen, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Regulation FD disclosure
Oct 15, 2026 Oct 15, 2026
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 15, 2026 Oct 13, 2026
4 Insider transaction Oct 13, 2026 Oct 9, 2026
144 Notice of proposed sale Oct 9, 2026 —
8-K Current report
Shareholder vote results
Oct 6, 2026 Oct 5, 2026
8-K Current report
Shareholder vote results
Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 11, 2026 Sep 9, 2026
144 Notice of proposed sale Sep 9, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 1, 2026
DEFA14A Additional proxy material Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
DEFA14A Additional proxy material Jul 30, 2026 —
DEF 14A Proxy statement Jul 30, 2026 Sep 21, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2026 —
PRE 14A Preliminary proxy statement Jul 20, 2026 Sep 21, 2026
8-K Current report
Other events
Jul 13, 2026 Jul 13, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results, Other events
Jun 11, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Jun 3, 2026 May 29, 2026
8-K Current report
Officer or director change, Other events
May 14, 2026 May 8, 2026
8-K Current report
New debt, Unregistered share sale, Regulation FD disclosure
May 14, 2026 May 14, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale
May 7, 2026 May 7, 2026
8-K Current report
Results of operations, Other events
May 5, 2026 May 5, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 4, 2026 May 4, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 28, 2026 Jun 11, 2026
PRER14A Filing Apr 20, 2026 —
PRE 14A Preliminary proxy statement Apr 17, 2026 Jun 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 14, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Regulation FD disclosure
Mar 27, 2026 Mar 26, 2026
8-K Current report
Regulation FD disclosure
Mar 24, 2026 Mar 24, 2026
8-K Current report
Other events
Mar 20, 2026 Mar 12, 2026
3 Initial insider ownership Mar 5, 2026 Mar 4, 2026
S-8 Employee stock plan registration Mar 4, 2026 —
10-K Annual report Mar 4, 2026 Dec 31, 2025
8-K Current report
Other events
Mar 4, 2026 Mar 4, 2026
8-K Current report
Results of operations
Mar 4, 2026 Mar 4, 2026
8-K Current report
Officer or director change
Feb 9, 2026 Feb 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 23, 2026 Jan 22, 2026
8-K Current report
Material agreement, Other events
Jan 21, 2026 Jan 20, 2026
424B5 Prospectus supplement Jan 21, 2026 —
8-K Current report
Other events
Jan 15, 2026 Jan 15, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
8-K Current report
Officer or director change
Dec 18, 2025 Dec 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Dec 8, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 31, 2025 —
8-K Current report
Agreement ended
Sep 18, 2025 Sep 16, 2025
8-K Current report
Material agreement
Sep 16, 2025 Sep 11, 2025
8-K Current report
Material agreement
Sep 5, 2025 Aug 29, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 11, 2025 Aug 8, 2025
424B5 Prospectus supplement Aug 11, 2025 —
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 1, 2025 Aug 1, 2025
8-K Current report
Other events
Jul 30, 2025 Jul 29, 2025
8-K Current report
Other events
Jul 29, 2025 Jul 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
8-K Current report
Listing notice
Jul 1, 2025 Jul 1, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jun 23, 2025 Jun 22, 2025
8-K Current report
Other events
Jun 17, 2025 Jun 16, 2025
3/A Amended initial statement of beneficial ownership of securities Jun 12, 2025 Jun 5, 2025
144 Notice of proposed sale Jun 11, 2025 —
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
3 Initial insider ownership Jun 9, 2025 Jun 5, 2025
3 Initial insider ownership Jun 9, 2025 Jun 5, 2025
8-K Current report
Shareholder vote results, Other events
Jun 5, 2025 Jun 5, 2025
8-K Current report
Results of operations
May 9, 2025 May 9, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 5, 2025
8-K Current report
Officer or director change
Apr 25, 2025 Apr 21, 2025
8-K Current report
Other events
Apr 4, 2025 Apr 4, 2025
S-8 Employee stock plan registration Mar 5, 2025 —
10-K Annual report Mar 5, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
EFFECT Filing Feb 13, 2025 —
8-K Current report
Other events
Feb 12, 2025 Feb 12, 2025
CORRESP Letter to the SEC Feb 11, 2025 —
8-K/A Amended current report
Material agreement, New debt, Unregistered share sale, Other events
Feb 7, 2025 Nov 6, 2024
UPLOAD Letter from the SEC Feb 6, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
S-3 Shelf registration Jan 31, 2025 —
8-K Current report
Other events
Jan 29, 2025 Jan 29, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Listing notice
Jan 3, 2025 Dec 31, 2024
8-K Current report
Other events
Dec 3, 2024 Dec 3, 2024
4 Insider transaction Dec 2, 2024 Nov 26, 2024
4 Insider transaction Nov 26, 2024 Nov 22, 2024
3 Initial insider ownership Nov 15, 2024 Nov 14, 2024
8-K Current report
Officer or director change
Nov 15, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 8, 2024 Nov 6, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
8-K Current report
Results of operations
Nov 8, 2024 Nov 8, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
SC 13G Ownership over 5% (passive) Oct 16, 2024 —
4 Insider transaction Sep 26, 2024 Sep 16, 2024
144 Notice of proposed sale Aug 16, 2024 —
8-K Current report
Other events
Aug 13, 2024 Aug 13, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Other events
Aug 5, 2024 Aug 5, 2024
424B5 Prospectus supplement Aug 1, 2024 —
8-K Current report
Material agreement, Other events
Aug 1, 2024 Jul 31, 2024
424B5 Prospectus supplement Jul 31, 2024 —
8-K Current report
Auditor change
Jul 8, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 17, 2024
8-K Current report
Shareholder vote results
Jun 28, 2024 Jun 28, 2024
DEFA14A Additional proxy material Jun 18, 2024 —
8-K Current report
Auditor change
Jun 6, 2024 May 31, 2024
ARS Annual report to shareholders May 28, 2024 Dec 31, 2023
DEF 14A Proxy statement May 28, 2024 Jun 28, 2024
PRE 14A Preliminary proxy statement May 17, 2024 Jun 28, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-A12G Form 8-a12g May 10, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
May 10, 2024 May 10, 2024
EFFECT Filing May 1, 2024 —
CORRESP Letter to the SEC Apr 29, 2024 —
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Apr 29, 2024 Apr 26, 2024
UPLOAD Letter from the SEC Apr 25, 2024 —
S-3 Shelf registration Apr 18, 2024 —
S-8 Employee stock plan registration Apr 18, 2024 —
4 Insider transaction Apr 17, 2024 Apr 16, 2024
10-K Annual report Apr 16, 2024 Dec 31, 2023
8-K Current report
Other events
Apr 8, 2024 Apr 8, 2024
8-K Current report
Results of operations
Apr 2, 2024 Apr 2, 2024
8-K Current report
Restatement, Other events
Apr 1, 2024 Apr 1, 2024
NT 10-K Filing Apr 1, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Mar 21, 2024 Mar 21, 2024
3 Initial insider ownership Mar 20, 2024 Mar 18, 2024
3 Initial insider ownership Mar 20, 2024 Sep 15, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 20, 2024 Mar 15, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 18, 2024 Mar 18, 2024
8-K Current report
Regulation FD disclosure
Feb 21, 2024 Feb 21, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 22, 2024 —
8-K Current report
Officer or director change
Jan 8, 2024 Jan 2, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
8-K Current report
Other events
Dec 22, 2023 Dec 22, 2023
8-K Current report
Other events
Nov 9, 2023 Nov 9, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Listing notice
Nov 2, 2023 Nov 2, 2023
UPLOAD Letter from the SEC Oct 12, 2023 —
8-K Current report
Other events
Oct 10, 2023 Oct 10, 2023
CORRESP Letter to the SEC Oct 4, 2023 —
8-K Current report
Officer or director change
Sep 19, 2023 Sep 15, 2023
4 Insider transaction Sep 19, 2023 Sep 16, 2023
UPLOAD Letter from the SEC Sep 19, 2023 —
8-K Current report
Other events
Sep 13, 2023 Sep 13, 2023
8-K Current report
Results of operations
Aug 22, 2023 Aug 22, 2023
8-K Current report
Results of operations
Aug 21, 2023 Aug 21, 2023
10-Q Quarterly report Aug 21, 2023 Jun 30, 2023
NT 10-Q Filing Aug 15, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Aug 15, 2023 Aug 14, 2023
SC 13G/A Amended ownership over 5% (passive) Jul 7, 2023 —
8-K Current report
Shareholder vote results
Jun 27, 2023 Jun 23, 2023
DEFA14A Additional proxy material Jun 21, 2023 —
4 Insider transaction Jun 20, 2023 Jun 16, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
OCGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Malvern, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1372299
Former names
HISTOGENICS CORP (until Sep 26, 2019)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.